Stimulator of interferon genes (STING) agonists can activate anti-tumor immune responses, and engineering small-molecule STING agonists into EVs effectively stimulates antigen-presenting cells and enhances anti-tumor immunity (118). The gene discussed is STING1; the disease is neoplasm.